New Electro-Mechanical Substrate Abnormalities in High-Risk Patients with Brugada Syndrome.
The relationship between the typical ECG pattern and electro-mechanical abnormalities has never been systematically explored in Brugada syndrome. Study aims were to characterize the electro-mechanical substrate in BrS patients, and to evaluate the relationship between electrical and mechanical abnormalities. We enrolled 50 consecutive high-risk BrS patients (aged 42±7.2 years), with ICD implantation for primary or secondary prevention of ventricular tachyarrhythmias (VT/VF), undergoing substrate mapping and ablation. Patients underwent 3D echocardiography with 3D wall motion/deformation quantification and electroanatomical mapping before/after Ajmaline (1 mg/kg in 5 min); 3D mechanical changes were compared with 50 age- and sex-matched controls. The effect of substrate ablation on electro-mechanical abnormalities was also assessed. In all patients, Ajmaline administration induced Brugada type 1 pattern, with a significant increase of the electrical substrate (P<0.001), particularly in patients with previous spontaneous VT/VF (P=0.007). Induction of Brugada pattern was associated with lowering of right ventricle (RV) ejection fraction (P<0.001) and worsening of 3D RV mechanical function (P<0.001), particularly in the anterior free wall of RVOT, without changes in controls. RV electrical and mechanical abnormalities were highly correlated (r=0.728, P<0.001). By multivariate analysis, only the area of RV dysfunction was an independent predictor of spontaneous VT/VF (OR: 1.480; 95% CI 1.159-1.889; P=0.002). Substrate ablation abolished both BrS-ECG pattern and mechanical abnormalities, despite Ajmaline re-challenge. BrS is an electromechanical disease affecting the RV. The typical BrS pattern reflects an extensive RV arrhythmic substrate, driving consistent RV mechanical abnormalities. Substrate ablation abolished both Brugada pattern and mechanical abnormalities.